Proprietary Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Proprietary Program. Real-time updates on events, politics, business and more.

Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results

November 14, 2023

LONDON--(BUSINESS WIRE)--Nov 14, 2023--

Hansoh Pharma Craig Tooman Exchange Commission On Mallinckrodt Pharmaceuticals Program Updates Corporate Communications

Source: eagletribune.com

Silence Therapeutics Reports Second Quarter 2023 Results

August 16, 2023

Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,... -Today at 07:03 am- MarketScreener

Craig Tooman Hansoh Pharma Program Updates Mallinckrodt Pharmaceuticals Exchange Commission On Silence Therapeutics

Source: marketscreener.com

Investegate |Silence Therapeutics Announcements | Silence Therapeutics: Silence Provides Pipeline Updates at 2021 R&D Day

October 21, 2021

Investegate announcements from Silence Therapeutics, Silence Provides Pipeline Updates at 2021 R&D Day

New York United States City Of United Kingdom Giles Campion Mark Rothera

Source: investegate.co.uk

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Proprietary Program News Today

Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results

Silence Therapeutics Reports Second Quarter 2023 Results

Investegate |Silence Therapeutics Announcements | Silence Therapeutics: Silence Provides Pipeline Updates at 2021 R&D Day

Explore More Categories